
Highlight Capital
Asia, Jiangsu, China, Nanjin'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Investor Profile
Highlight Capital has made 28 investments, with 11 in the past 12 months and 43% as lead.
Stage Focus
- Seed (21%)
- Series C (21%)
- Series A (21%)
- Series Unknown (11%)
- Series B (11%)
- Series D (7%)
- Post Ipo Equity (4%)
- Debt Financing (4%)
Country Focus
- China (75%)
- United States (18%)
- Indonesia (4%)
- South Korea (4%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Manufacturing
- Internet
- Biopharma
- Artificial Intelligence (Ai)
- Robotics
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.